tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

LYPHF Stock Latest News

Luye Pharma Group Announces 2025 Annual General Meeting
Company AnnouncementsLuye Pharma Group Announces 2025 Annual General Meeting
4d ago
Luye Pharma Launches Rotigotine Patch in UK, Expands CNS Treatment Portfolio
PremiumCompany Announcements
Luye Pharma Launches Rotigotine Patch in UK, Expands CNS Treatment Portfolio
23d ago
Luye Pharma’s Antidepressant Ruoxinlin® Gains Approval in Macao
PremiumCompany Announcements
Luye Pharma’s Antidepressant Ruoxinlin® Gains Approval in Macao
26d ago
Luye Pharma’s Rivastigmine Patch Gains Approval in Japan
PremiumCompany Announcements
Luye Pharma’s Rivastigmine Patch Gains Approval in Japan
1M ago
Luye Pharma Reports Mixed Financial Results for 2024
PremiumCompany Announcements
Luye Pharma Reports Mixed Financial Results for 2024
1M ago
Luye Pharma Group Schedules Board Meeting to Approve Annual Results and Dividend
PremiumCompany AnnouncementsLuye Pharma Group Schedules Board Meeting to Approve Annual Results and Dividend
2M ago
Luye Pharma upgraded to Neutral from Sell at Goldman Sachs
Premium
The Fly
Luye Pharma upgraded to Neutral from Sell at Goldman Sachs
2M ago
Luye Pharma Initiates Phase II Trial for CNS Drug LY03015 in China
Premium
Company Announcements
Luye Pharma Initiates Phase II Trial for CNS Drug LY03015 in China
4M ago
Luye Pharma’s New Antipsychotic Drug LY03020 Approved for U.S. Clinical Trials
PremiumCompany Announcements
Luye Pharma’s New Antipsychotic Drug LY03020 Approved for U.S. Clinical Trials
4M ago
Luye Pharma Chairman Increases Stake, Signals Confidence
PremiumCompany Announcements
Luye Pharma Chairman Increases Stake, Signals Confidence
5M ago
Luye Pharma Announces Convertible Bond Issuance
PremiumCompany Announcements
Luye Pharma Announces Convertible Bond Issuance
5M ago
Luye Pharma Bolsters Liquidity with $50M Bond Issue
PremiumCompany Announcements
Luye Pharma Bolsters Liquidity with $50M Bond Issue
5M ago
Luye Pharma Gains Approval for Cancer Drug Zepzelca
PremiumCompany AnnouncementsLuye Pharma Gains Approval for Cancer Drug Zepzelca
5M ago
Luye Pharma Gains Ground with New Drug Inclusions
Premium
Company Announcements
Luye Pharma Gains Ground with New Drug Inclusions
5M ago
Luye Pharma Gains Approval for Innovative Antidepressant Trials
Premium
Company Announcements
Luye Pharma Gains Approval for Innovative Antidepressant Trials
6M ago
Luye Pharma’s $100 Million Convertible Bonds Issuance
PremiumCompany Announcements
Luye Pharma’s $100 Million Convertible Bonds Issuance
6M ago
Luye Pharma Boosts Liquidity with $100M Bond Issue
PremiumCompany Announcements
Luye Pharma Boosts Liquidity with $100M Bond Issue
6M ago
Luye Pharma Adjusts Closing Date for Bond Issue
PremiumCompany Announcements
Luye Pharma Adjusts Closing Date for Bond Issue
6M ago
Luye Pharma Group to Issue $150M Convertible Bonds
PremiumCompany Announcements
Luye Pharma Group to Issue $150M Convertible Bonds
6M ago
Luye Pharma Group Reports Strong Mid-Year Financials
PremiumCompany AnnouncementsLuye Pharma Group Reports Strong Mid-Year Financials
8M ago
Luye Pharma Sets Date for Financial Results Review
Premium
Company Announcements
Luye Pharma Sets Date for Financial Results Review
9M ago
Luye Pharma Group Completes Key Investment Phase
Premium
Company Announcements
Luye Pharma Group Completes Key Investment Phase
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >